Form D · Other
NOLA PharmaHoldings, LLC
Little Rock, AR · CIK 0002023766
Offering snapshot reported May 23, 2024 · SEC filing
- Reported sold
- $48.1M Offering amount: $65.5M
- Investors reported
- 111 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 10, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 23, 2024 | Initial | $48,115,000 | No comparison | 111 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-514123
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed May 23, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peyton Bush | Director |
| Todd Denton | Director |
| Reid Dove | Director |
| Terry Fitch | Director |
| Alex Gray | Executive |
| Mitchell Massey | Director |
Issuer details
Industry: Other (See others in industry)
Address:
425 W Capitol Avenue Suite 1400
Little Rock, AR, 72201
Little Rock, AR, 72201